For years, the sense of smell has remained an underrated and under-discussed sense in medical conversations. It is often taken for granted, fading quietly into the background until it begins to falter. Most people associate a fading sense of smell with aging or seasonal allergies. Few would imagine that it could hint at something far more serious i.e. a warning from the body about the heart’s health. Yet, new research suggests precisely that. According to a recent study published in JAMA Otolaryngology–Head & Neck Surgery, older adults who experience a diminished sense of smell, a condition medically known as olfactory decline, may have nearly double the risk of developing coronary heart disease. The finding challenges conventional understanding of cardiovascular risk factors, indicating that something as subtle as a loss of smell could serve as an early alarm for heart trouble.

The study, conducted by researchers led by Keran W. and colleagues, draws upon data from one of the largest and most respected cardiovascular research efforts in the world i.e. the Atherosclerosis Risk in Communities (ARIC) Study. This long-term study has followed thousands of participants over decades to understand the evolution of heart disease and related disorders. By analysing secondary data from more than 5,000 participants aged around 75 years, the researchers found a striking pattern: those with poor olfaction faced a significantly higher chance of developing heart-related conditions, particularly within the first few years of observation.

Smell, it turns out, is not merely about identifying fragrances or savoring food aromas, it’s deeply intertwined with the body’s physiological and neurological processes. The olfactory system is closely linked with the brain regions that regulate memory, emotion, and even metabolic function. It is also highly vascularized, meaning it depends on healthy blood circulation. When this sense begins to decline, it may reflect underlying issues in vascular health, inflammation, or neural degeneration, all of which are closely connected to heart disease.

The study’s results were drawn from a meticulous evaluation of olfactory function through a 12-item odor identification test. Participants were grouped into categories based on their ability to recognize scents: good, moderate, or poor. Over nearly a decade of follow-up, researchers observed that those with poor smell perception experienced a significantly higher rate of coronary events such as heart attacks or coronary death, especially in the early years. By the second year, the risk of coronary heart disease was more than twice as high among participants with poor smell compared to those with good olfactory function. Even after accounting for traditional risk factors like blood pressure, cholesterol, smoking habits, and age, the association persisted, indicating that smell loss independently contributes to heart disease risk.

This connection between olfaction and heart health opens a new dimension in medical science, suggesting that the nose might be an unexpected diagnostic window into cardiovascular wellness. While the link between smell loss and neurodegenerative diseases like Parkinson’s and Alzheimer’s has long been recognized, its association with heart disease adds another layer to how physicians may interpret sensory decline in aging adults. The olfactory bulb, which processes smell, is one of the few areas in the brain where nerve regeneration continues throughout life. Any disturbance in this delicate system could hint at vascular or inflammatory dysfunction, processes central to the development of coronary artery disease.

For decades, cardiologists have focused on well-known markers such as hypertension, cholesterol imbalance, diabetes, obesity, and smoking. However, as this research suggests, the body might be offering subtle sensory warnings years before a clinical event occurs. Poor smell could serve as a non-invasive and inexpensive biomarker for identifying individuals at risk. It is a revelation that could reshape early detection strategies for cardiovascular disease, allowing for interventions before irreversible damage sets in.

The implications of this study are far-reaching. It invites both clinicians and patients to rethink the significance of sensory health as a mirror of overall well-being. The fact that smell loss appears to precede heart problems by several years hints at a lag period where preventive measures could make a critical difference. Early lifestyle interventions such as maintaining blood pressure, reducing inflammation through diet, improving sleep, and staying physically active could potentially mitigate the underlying mechanisms connecting olfactory loss and heart vulnerability.

The findings also shed light on a growing public health concern: sensory decline in older adults is often dismissed or left uninvestigated. Many people, especially those above 60, experience gradual loss of smell due to changes in the nasal epithelium or reduced regeneration of olfactory neurons. However, in the absence of obvious nasal disease, this decline could be the body’s way of signaling vascular distress. Unfortunately, routine medical check-ups rarely include olfactory testing. A simple smell identification test, if integrated into geriatric screenings, could become a powerful addition to cardiovascular risk assessment tools.

Researchers speculate several possible mechanisms behind this association. One theory points to systemic inflammation which is a common denominator in both heart disease and sensory decline. Chronic inflammation affects the vascular endothelium, narrowing arteries and reducing blood flow to both the heart and the brain. Another possibility is that reduced olfactory function could be a symptom of small vessel disease, where microvascular damage compromises oxygen supply to multiple organs, including those responsible for smell. Hormonal and metabolic changes associated with aging could further amplify these risks, making the sense of smell an indirect but reliable indicator of heart health.

Interestingly, the study also noted that this risk appeared most pronounced during the early years after olfactory testing, gradually decreasing over time. This suggests that poor smell may reflect active disease processes already underway rather than a long-term static condition. It could, therefore, serve as a short-term predictive marker alerting clinicians to those who need immediate cardiovascular evaluation.

While this research focused on an older population, it raises broader questions about how modern lifestyles marked by pollution, respiratory infections, and prolonged mask use during the pandemic might influence olfactory function and, indirectly, cardiovascular risk across age groups. Post-COVID smell loss, for instance, has affected millions globally. Could persistent anosmia in middle-aged adults today become a precursor to higher heart disease rates tomorrow? The question warrants deeper exploration.

For older adults, the message is both empowering and cautionary. Paying attention to subtle sensory changes can offer life-saving clues. Something as simple as failing to detect familiar fragrances or flavors should prompt medical evaluation. Early testing for cardiovascular risk factors, combined with lifestyle modifications, could prevent severe outcomes. The human body is a network of interconnected systems, and when one sense begins to fade, it might be a sign that another organ is under stress.

Beyond clinical implications, this discovery also touches an emotional chord. The loss of smell affects quality of life where food loses its flavor, flowers lose their charm, and familiar environments feel strangely dull. This sensory void can lead to anxiety, isolation, and depression, which themselves are risk factors for cardiovascular disease. Thus, olfactory decline could influence heart health both biologically and psychologically, reinforcing the deep and subtle connections between the body and mind.

Future research will likely expand upon these findings, exploring whether interventions that preserve or restore olfactory function could, in turn, reduce cardiovascular risk. It also opens possibilities for using olfactory testing as part of wearable health technology or digital health platforms, allowing for early and continuous monitoring in aging populations. The idea that a small handheld smell test could one day help prevent a heart attack might seem futuristic, but it’s a possibility firmly grounded in emerging science.

As medical understanding evolves, the definition of “heart health” itself is broadening. It is no longer limited to cholesterol counts and ECG readings; it is about the overall harmony of the body’s systems. The nose, once dismissed as peripheral, is now entering the spotlight as a sentinel of systemic health. It senses not only the scents of the world but the silent stirrings of disease within.

The study is a call to awareness. It invites the medical community to look beyond the obvious and to consider the body’s subtler signals. It asks people to listen more closely to their senses, to notice when something feels off, and to treat sensory decline as a legitimate medical concern rather than a mere inconvenience of aging.

As the research continues, one truth becomes clear: health is a conversation between the senses and the organs, between perception and physiology. And sometimes, the first sign of a struggling heart is not in the chest but in the silent loss of scent that lingers in the air, waiting to be noticed.